Bogdan Z.
- Country
- Poland
- Department
- Centrum Onkologii
Research Overview
- Phase 3 Randomized Study of Nivolumab and Ipilimumab with Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer
- Efficacy and Safety of Durvalumab and Novel Anti-Cancer Agents With/Without Chemotherapy in Treatment-Naïve Metastatic Non-Small Cell Lung Cancer
- Comparative Study of JPB898 and Nivolumab in Combination with Ipilimumab for Advanced Unresectable/Metastatic Melanoma
Data & Insights
Has run more than one trial at 724 of 1053 partner sites.
Specializations
Thoracic Oncology
The investigator specializes in treating non-small cell lung cancer across various stages, including early-stage non-squamous NSCLC and metastatic squamous NSCLC. Their research extends to locally advanced unresectable NSCLC with particular attention to PD-L1 expressing tumors.
- Advanced Stage Treatment
- Immunotherapy Applications
- Combined Therapeutic Approaches
Genitourinary Cancers
Focus areas include metastatic renal cell carcinoma and prostate cancer, specifically metastatic hormone-sensitive prostate cancer and metastatic castration-resistant prostate cancer. The investigator also studies muscle-invasive bladder cancer.
- Novel Treatment Combinations
- Targeted Therapies
- Hormone-Based Treatments
Advanced Solid Tumors
Research encompasses multiple solid tumor types including triple negative breast cancer, metastatic colorectal cancer, and advanced melanoma. Additional focus on head and neck squamous cell carcinoma and cutaneous squamous cell carcinoma.
- Immunotherapy Integration
- Neoadjuvant Approaches
- Multimodal Treatment Strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.